Skip to content
Sunday, November 8, 2026
Pulse Poker 206

{‘She lacks little experience’: this American healthcare field girds for Høeg's appointment at the FDA.

As the United States proceeds with historic adjustments to its vaccine schedules, a particular individual has emerged unexpectedly: Dr. Tracy Beth Høeg, a US-based sports medicine doctor and epidemiologist who initially gained attention by expressing skepticism about coronavirus shots during the pandemic and has focused upon alleged fatalities following Covid vaccination in her recent time at the Food and Drug Administration.

Planned Shifts to Pediatric Immunization Schedule

Agency leaders were set to announce radical revisions to the pediatric vaccination calendar in December, aligning the US with Denmark’s vaccine program, it is understood – a significant shift that would place the US out of alignment with many the international standard with little proof for improved outcomes. The planned update has been postponed until the new year.

Rather than Vinay Prasad, Høeg is scheduled to address the audience at the gathering. She was newly appointed acting director of the FDA’s CDER, the fifth individual to head the center this calendar year.

Consolidating Power at the FDA

The acting appointment might represent a tighter collaboration between the drug and vaccine centers as Dr. Høeg and Dr. Prasad solidify control at the agency – and it signals a greater focus upon dismantling previously authorized vaccines at the FDA.

The new acting director has frequently advocated for discontinuing some pediatric immunization guidelines in the US in order to be more in line with the Danish model, a country with comprehensive healthcare and a population approximately the size of Wisconsin’s.

In her initial comments, she has continued to focus on vaccination policy – traditionally the responsibility of Dr. Prasad, head of the FDA’s Center for Biologics Evaluation and Research (CBER) – instead of pharmaceutical oversight.

Questions Over Expertise

The appointee has no apparent track record in medication creation, approval processes or management, which has been standard for past leaders of the biologics center. She has worked at the FDA as a top consultant to the commissioner and the vaccine center since spring.

“She appears not to have the necessary background” for overseeing the CDER, stated Jonathan Howard. “She lacks experience running a randomized controlled trial. She lacks experience in running a major agency. She is not an expert in industry regulation.”

Previous heads of the center would “grasp regulatory frameworks and the research of drug development”, noted Dr. Janet Woodcock. “Clearly, she has not acquired the sort of resume that previous people who headed the center have had.”

The drug center has an vast portfolio at the agency, the former commissioner emphasized.

“Many people just pays attention on the novel medication approvals, but the generic program approves a multitude of generic drugs. There’s a biosimilars division, OTC medication office and so forth, and each of these need to be supervised,” she noted. “The responsibility you neglect, that is the part that I always told people is going to cause problems.”

There is also, a significant leadership component to the position, which oversees in excess of 5,000 employees. “It’s a massive management job, if you execute it properly,” the former official added.

Agency Reaction and Disputed Policies

Regarding questions about Høeg’s credentials and whether this appointment signifies increased cooperation among regulatory chiefs on vaccines, a representative stated that the “questions rely on incorrect presumptions”.

“Her experience aligns with the duties of her job,” the spokesperson said, pointing to the time Høeg spent guiding the FDA commissioner on “medication safety and approval science, including predictive safety algorithms and vaccine surveillance”.

In her interim role, Høeg assumes responsibility for the agency head's controversial expedited review system, a controversial rapid therapy clearance system that apparently troubled her predecessors. “How are these drugs being selected for this expedited pathway? Who takes the calls?” Howard questioned. “There is a lot of lack of transparency happening at the regulatory body right now.”

Overall, he said, “the Food and Drug Administration seems to be moving towards more relaxed rules of most medications, aside from shots.”

Documented Past Work on Immunizations

Regarding vaccines, Høeg has a clearer, if troubling, history, critics have noted. She published a analysis using unconfirmed public submissions to assess the rate of heart inflammation following Covid immunization. She consulted for the Florida surgeon general Joseph Ladapo, who was said to have changed statistics to imply Covid vaccines are riskier than they are.

Included in her “desired changes” for the new federal leadership featured revising regulations for novel immunizations and ending “non-essential” immunizations, she remarked following the vote on a podcast. At the agency, Høeg has allegedly proposed preventing teenage boys from getting Covid vaccines.

“She is an thorough true believer who commences with her conclusions and tailors the evidence to fit the evidence in a extremely disingenuous, fraudulent way,” Howard argued.

Taking Control and a “Revenge Tour”

Høeg aligned with fellow skeptics, {like|

The writer

Robert Lee

Elara Vance is a professional poker player and analyst with over a decade of experience in high-stakes tournaments and strategy coaching.

Pulse Poker 206

Type to search articles.